Target intelligence / Profile preview

Indian Cobra (Naja naja) venom toxins (NNV)

Target
NNV
Molecular classification
Three-finger toxin, Phospholipase A2, Snake venom metalloproteinase, L-amino acid oxidase, Enzyme, Toxin
01

Overview

Indian Cobra venom toxins are a complex mixture of bioactive proteins and peptides secreted by the venom glands of the Naja naja species (UniProt, 2024). The primary toxic components include three-finger toxins (3FTxs), such as alpha-neurotoxins and cardiotoxins, as well as enzymes like phospholipase A2 (PLA2) and snake venom metalloproteinases (SVMPs) (PubMed, PMID: 31911634). These toxins function by disrupting critical physiological processes in the victim; alpha-neurotoxins specifically target the nicotinic acetylcholine receptors (nAChR) at the neuromuscular junction, leading to flaccid paralysis and potentially fatal respiratory failure (StatPearls, 2023). Cardiotoxins, another major component, cause localized tissue necrosis and systemic cardiovascular collapse by disrupting cell membrane integrity and inducing depolarization in excitable tissues (Wikipedia, 2024). In a clinical context, these toxins are the primary targets for neutralization by polyvalent or monovalent antivenoms, which consist of purified antibodies that bind and sequester the venom components to prevent their interaction with host tissues (WHO, 2024). Emerging small-molecule inhibitors, such as varespladib, are also being investigated to target specific enzymatic components like PLA2 to mitigate both local and systemic toxicity (Journal of Medicinal Chemistry, 2016).

Other names
Naja naja venomCobra venom proteinsAlpha-neurotoxinsCardiotoxinsCytotoxins3FTxs
02

Mechanism of action

Antibody-mediated neutralization of venom proteins and competitive inhibition of enzymatic components like phospholipase A2.

03

Biological functions

Neuromuscular blockadeCell membrane disruptionProteolysisHemolysisInhibition of platelet aggregation
04

Disease associations

Snakebite envenomationRespiratory failureTissue necrosisOther
05

Safety considerations

AnaphylaxisSerum sicknessPyrogenic reactionsRapid progression of paralysis
06

Interacting drugs

Polyvalent antivenom

5 more in the full profile.

07

Biomarkers

Venom antigen levelsCreatine kinaseProthrombin timeClinical neurotoxicity signs

Beyond the preview

Go deeper on Indian Cobra (Naja naja) venom toxins (NNV).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Indian Cobra (Naja naja) venom toxins (NNV).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call